In a report released today, Suraj Kalia from Northland Securities maintained a Sell rating on Intuitive Surgical (ISRG), with a price target of $375. The company’s shares opened today at $510.47.
Kalia wrote:
“We are tweaking our models accordingly, and are introducing our FY20 numbers. Key Points Instrument & Accessory revs @ $539M vs. our estimate @ $535M. Systems revs @ $340M vs. our estimate @ $327M.”
According to TipRanks.com, Kalia is a 5-star analyst with an average return of 9.7% and a 55.6% success rate. Kalia covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Strata Skin Sciences Inc, and Obalon Therapeutics Inc.
Currently, the analyst consensus on Intuitive Surgical is a Strong Buy with an average price target of $603.13.
See today’s analyst top recommended stocks >>
Based on Intuitive Surgical’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $293 million. In comparison, last year the company had a GAAP net loss of $38.8 million.
Based on the recent corporate insider activity of 89 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
